a genomic test co-invented by researchers at the university of british columbia may help millions of breast cancer patients avoid chemotherapy. the test's potential to spare patients from chemotherapy is being reported, although details of the test and its effects are not specified. the university is also involved in various other medical research projects, but the genomic test is the one mentioned in relation to breast cancer patients.